Showing results (481-490 of 758) with videos related to

Sort By:
Pageof 76
Thrombosis and Haemostasis|February 5, 2009
Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodiesElena Bresin, Sara Gastoldi, Erica Daina, et al.
American Journal of Physiology. Renal Physiology|September 7, 2012
Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathyCarla Zoja, Pablo Bautista Garcia, Cinzia Rota, et al.
Stem Cell Research|June 15, 2016
Generation of functional podocytes from human induced pluripotent stem cellsOsele Ciampi, Roberto Iacone, Lorena Longaretti, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 22, 2022
Estimated Lifetime Benefit of Combined RAAS and SGLT2 Inhibitor Therapy in Patients with Albuminuric CKD without DiabetesPriya Vart, Muthiah Vaduganathan, Niels Jongs, et al.
Kidney International|August 8, 2002
Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1Carla Zoja, Stefania Angioletti, Roberta Donadelli, et al.
JCI Insight|March 13, 2020
C3a receptor blockade protects podocytes from injury in diabetic nephropathyMarina Morigi, Luca Perico, Daniela Corna, et al.
JCI Insight|September 20, 2019
Alteration of thyroid hormone signaling triggers the diabetes-induced pathological growth, remodeling, and dedifferentiation of podocytesValentina Benedetti, Angelo Michele Lavecchia, Monica Locatelli, et al.
Journal of the American Society of Nephrology : JASN|June 7, 2014
A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulationElisabetta Valoti, Marta Alberti, Agustin Tortajada, et al.
Pageof 76